MAPK3 and neuroblastoma: In line with these clinical evidences, the overexpression of CasR in neuroblastoma cell lines significantly reduced the proliferation and activated apoptosis through ERK1/2, while the calcimimetic cinacalcet reduced the growth of neuroblastoma due to a promotion of the differentiation, ER stress and apoptosis [110].